A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 745,334 shares of ASRT stock, worth $633,533. This represents 0.0% of its overall portfolio holdings.

Number of Shares
745,334
Previous 974,534 23.52%
Holding current value
$633,533
Previous $1.21 Million 27.24%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.07 - $1.75 $245,244 - $401,100
-229,200 Reduced 23.52%
745,334 $879,000
Q2 2024

Aug 14, 2024

SELL
$0.75 - $1.31 $116,250 - $203,050
-155,000 Reduced 13.72%
974,534 $1.21 Million
Q1 2024

May 15, 2024

SELL
$0.79 - $1.14 $71,795 - $103,604
-90,881 Reduced 7.45%
1,129,534 $1.08 Million
Q4 2023

Feb 14, 2024

BUY
$1.02 - $2.57 $740,806 - $1.87 Million
726,281 Added 146.98%
1,220,415 $1.31 Million
Q3 2023

Nov 14, 2023

BUY
$2.52 - $5.69 $720,468 - $1.63 Million
285,900 Added 137.3%
494,134 $1.26 Million
Q2 2023

Aug 14, 2023

BUY
$5.0 - $7.66 $116,625 - $178,669
23,325 Added 12.61%
208,234 $1.13 Million
Q1 2023

May 15, 2023

SELL
$3.54 - $6.66 $427,012 - $803,362
-120,625 Reduced 39.48%
184,909 $1.18 Million
Q4 2022

Feb 14, 2023

BUY
$2.11 - $4.3 $465,003 - $947,638
220,381 Added 258.81%
305,534 $1.31 Million
Q3 2022

Nov 14, 2022

BUY
$2.13 - $4.0 $35,044 - $65,812
16,453 Added 23.95%
85,153 $193,000
Q2 2022

Aug 15, 2022

BUY
$1.88 - $3.42 $14,476 - $26,334
7,700 Added 12.62%
68,700 $203,000
Q1 2022

May 16, 2022

SELL
$2.06 - $3.0 $11,536 - $16,800
-5,600 Reduced 8.41%
61,000 $175,000
Q4 2021

Feb 14, 2022

BUY
$0.86 - $2.3 $43,258 - $115,689
50,300 Added 308.59%
66,600 $145,000
Q3 2021

Nov 15, 2021

BUY
$0.89 - $1.55 $14,507 - $25,265
16,300 New
16,300 $15,000

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $41M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.